Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 15,726	$ 8,033
General and administrative	8,424	5,460
Total operating expenses	24,150	13,493
Loss from operations	(24,150)	(13,493)
Other income (expense):
Interest and investment income	4,241	2,321
Other expense, net	(19)	(16)
Total other income, net	4,222	2,305
Net loss	$ (19,928)	$ (11,188)
Net loss per share attributable to common shareholders - basic	$ (0.38)	$ (0.40)
Net loss per share attributable to common shareholders - diluted	$ (0.38)	$ (0.40)
Weighted-average common shares outstanding used in net loss per share - basic	52,294,765	27,944,458
Weighted-average common shares outstanding used in net loss per share - diluted	52,294,765	27,944,458